iNtRON Biotechnology Inc Capital Reinvestment Ratio
iNtRON Biotechnology Inc capital reinvestment ratio. iNtRON Biotechnology Inc (048530) has a Capital Reinvestment Ratio of 0.17x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩1.94 Billion) in capital expenditures (₩321.62 Million). Check iNtRON Biotechnology Inc (048530) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of iNtRON Biotechnology Inc (2015–2023)
Capital reinvestment ratio of iNtRON Biotechnology Inc from 2015 to 2023. This chart tracks iNtRON Biotechnology Inc's Capital Reinvestment Ratio across 6 annual periods. Also explore iNtRON Biotechnology Inc (048530) equity growth momentum to track the company's year-over-year net asset growth rate.
iNtRON Biotechnology Inc Capital Reinvestment Ratio by Year (2015–2023)
iNtRON Biotechnology Inc capital reinvestment ratio by year from 2015 to 2023. For the full cash flow conversion analysis, see 048530 cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 3.06x | ₩3.12 Billion | ₩9.55 Billion | ▲ +721.6% |
| 2022 | 0.37x | ₩5.98 Billion | ₩2.23 Billion | ▲ +101.6% |
| 2021 | 0.18x | ₩16.47 Billion | ₩3.05 Billion | ▼ -72.8% |
| 2020 | 0.68x | ₩7.13 Billion | ₩4.85 Billion | ▲ +419.1% |
| 2018 | 0.13x | ₩4.20 Billion | ₩550.58 Million | ▼ -96.5% |
| 2015 | 3.71x | ₩1.70 Billion | ₩6.30 Billion | — |